India's cumulative Covid vaccination coverage exceeds 1.81 bn

India's COVID-19 vaccination coverage has exceeded 181.21 crores (1,81,21,11,675) as per provisional reports till 7 am today, informed the Ministry of Health and Family Welfare on Sunday

Topics
Coronavirus Vaccine | Coronavirus Tests | Coronavirus

ANI 

India's COVID-19 vaccination coverage has exceeded 181.21 crores (1,81,21,11,675) as per provisional reports till 7 am today, informed the Ministry of Health and Family Welfare on Sunday.

According to the ministry, this has been achieved through over 2 crore sessions.

COVID-19 vaccination for the age group 12-14 years was started on March 16, 2022. So far, more than 17 lakh adolescents have been administered the first dose of the COVID-19 vaccine, said the ministry.

It further stated that following a continuous downward trend, India's active caseload has declined to 26,240 today, constituting 0.06 per cent of the country's total positive cases.

Consequently, India's recovery rate stands at 98.74 per cent.

In the last 24 hours, India reported 1,761 new cases whereas 3,196 patients have recovered from the infection and the cumulative tally of recovered patients since the beginning of the pandemic is now at 4,24,65,122.

A total of 4,31,973 COVID-19 tests were conducted in the last 24 hours. So far, India has conducted over 78.26 crores (78,26,60,658) cumulative tests.

There has been a sustained fall in the weekly and daily Positivity Rates too. The weekly Positivity Rate in the country currently stands at 0.41 per cent and the Daily Positivity rate is also reported to be 0.41 per cent.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sun, March 20 2022. 19:26 IST
RECOMMENDED FOR YOU